C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor

Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
10/2002
10/17/2002	US20020151488 G-CSF analog compositions and methods
10/17/2002	US20020151487 Method and reagents for epithelial barrier formation and treatment of malignant and benign skin disorders by modulating the notch pathway
10/17/2002	US20020151484 SID nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof
10/17/2002	US20020151483 C3b/C4b complement receptor-like molecules and uses thereof
10/17/2002	US20020151479 Nucleic acids, proteins, and antibodies
10/17/2002	US20020151478 Fusion protein comprising a latency associated peptide and a proteolytic cleavage site wherein the fusion protein is associated with a pharmaceutically active agent; gene therapy; genetic engineering; antiinflammatory agents
10/17/2002	US20020151476 An isolated and purified antiviral protein or peptide from Nostoc ellipsosporum; viricides; coupled to an effector molecule; inhibits replication of a virus, e.g. a retrovirus, in particular a human immunodeficiency virus, HIV
10/17/2002	US20020151475 Compounds and methods for modulating cell adhesion
10/17/2002	US20020151460 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
10/17/2002	US20020151067 Nucleotide sequences coding polypeptide for use in the treatment of viral diseases
10/17/2002	US20020151066 Propagating cells which generate preferential neurotransmitters; obtain premature neuronal cells, transform with vector, express polypeptide, monitor cells and evaluate for neurotransmitter phenotype
10/17/2002	US20020151065 Induction of beta cell differentiation in human cells by stimulation of the GLP-1 receptor
10/17/2002	US20020151056 Inducing cell differentiation in embryonic cells; obtain cells, inoculate nutrient broths, propagate cells, recover cells
10/17/2002	US20020151055 Novel artificial pancreas
10/17/2002	US20020151054 Cellular production control
10/17/2002	US20020151053 Generation of preferential cells in culture; generate nutrient broth, inoculate with cells, propagate, recover preferential cells
10/17/2002	US20020151050 Isolation of spore-like cells from tissues exposed to extreme conditions
10/17/2002	US20020151049 Self-enhancing, pharmacologically controllable expression systems
10/17/2002	US20020151032 Generation of preferential viral vector; obtain cell, incubate with viral nucleotide sequences, propagate, recover nucleotide sequences
10/17/2002	US20020151027 Viral fiber protein for use in the treatment of viral diseases
10/17/2002	US20020151022 Kinase capable of site-specific phosphorylation of IkappaBalpha
10/17/2002	US20020151021 Stimulus-inducible protein kinase complex and methods of use therefor
10/17/2002	US20020151017 Methods for obtaining a polynecleotide encoding a polypeptide having a rubisco activity
10/17/2002	US20020151015 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
10/17/2002	US20020151009 Human polynucleotides, polypeptides, and antibodies
10/17/2002	US20020150995 Methods for producing sialyloligosaccharides in a dairy source
10/17/2002	US20020150993 Nucleotide sequences coding polypeptide for use in the treament of apoptosis, inflammatory or autoimmune diseases
10/17/2002	US20020150992 Nucleotide sequences coding polypeptide for us ein the treatment of immunological disorders
10/17/2002	US20020150989 Human tumor necrosis factor receptor
10/17/2002	US20020150988 Nucleotide sequences coding polypeptide for use in the forensic analysis and diagnosis and treatment of genetic disorders
10/17/2002	US20020150986 Extracellular matrix signalling molecules
10/17/2002	US20020150981 Methods for producing highly phosphorylated lysosomal hydrolases
10/17/2002	US20020150980 Nucleotide sequences coding protein for use in the treatment of asthma, parkinson's, heart, hypotension, osteporosis and urogenital disorders
10/17/2002	US20020150977 Nucleotide sequences coding protein for use in the diagnosis, treatment and prevention of autoimmune, cell proliferative and inflammatory diseases
10/17/2002	US20020150976 Nucleotide sequences coding polypeptide for use in the treatment of arthritis and bone disorders
10/17/2002	US20020150974 Polypeptide for use in the diagnosis and treatment of osteoporosis and brain disorders
10/17/2002	US20020150972 Nucleotide sequences coding polypeptide for use in the treatment of cancer
10/17/2002	US20020150951 Recovering preferential cells from sample; generate solid support, incubate with cell sample, elute and recover cells
10/17/2002	US20020150931 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of preferential genetic disorder
10/17/2002	US20020150928 Amplification preferential nucleotide sequences in sample; obtain sample nucleotide sequences, store in preservation fluid, drain fluid, recover nucleotide sequence amplify sequences, evaluate nucleotide sequences
10/17/2002	US20020150918 Method for detection of biological factors in epidermis
10/17/2002	US20020150913 Cell extract for use in the generation of preferential nucleotide sequences
10/17/2002	US20020150912 Expression vector for use as diagnostic tool in genetic engineering and analysis
10/17/2002	US20020150902 Polymorphic loci that differentiate escherichia coli 0157:H7 from other strains
10/17/2002	US20020150888 Methods of screening for modulators of HIV infection
10/17/2002	US20020150879 Three-demensional ex vivo angiogenesis system
10/17/2002	US20020150753 Porous, biodegradable polymer; tissue culture
10/17/2002	US20020150604 Device and method for tissue engineering
10/17/2002	US20020150603 Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
10/17/2002	US20020150591 Amplification nucleic acids
10/17/2002	US20020150587 Immunological polypeptides; vaccine against gramnegative bacteria
10/17/2002	US20020150586 Novel amino acid sequences, DNA encoding the amino acid sequences, antibodies directed against such sequences and the different uses thereof
10/17/2002	US20020150577 Transforming growth factor; transgenic animal; increas ratios of muscle mass
10/17/2002	US20020150574 Cancer diagnosis, therapy; Dna vaccine
10/17/2002	US20020150571 Antibodies specific for native PrPSc
10/17/2002	US20020150570 Anti-CCR2 antibodies and methods of use therefor
10/17/2002	US20020150569 Using monoclonal antibodies
10/17/2002	US20020150562 Viral preparations, vectors, immunogens, and vaccines
10/17/2002	US20020150561 Cell proliferation; culture product
10/17/2002	US20020150559 Binding of human antigens
10/17/2002	US20020150558 Immobilization; viricides
10/17/2002	DE10201458A1 New proteins involved in isoprenoid biosynthesis, useful in screening for inhibitors, also new intermediates, potential therapeutic agents, nucleic acids and antibodies
10/17/2002	DE10117205A1 Vorrichtung zur Vorbereitung von Zellen für die Kryokonservierung Device for preparation of cells for the cryopreservation
10/17/2002	CA2699611A1 Desaturase genes and uses thereof
10/17/2002	CA2698579A1 Desaturase genes and uses thereof
10/17/2002	CA2446462A1 Chimeric vaccines
10/17/2002	CA2443813A1 Method for identification of proteins from intracellular bacteria
10/17/2002	CA2443377A1 D-hydantoinase from ochrobactrum anthropi
10/17/2002	CA2443372A1 Immunotherapeutic combinations for the treatment of tumors that over-express gangliosides
10/17/2002	CA2443341A1 Human gene critical to fertility
10/17/2002	CA2443334A1 Protein modification and maintenance molecules
10/17/2002	CA2443323A1 Nucleic acid vaccines for prevention of flavivirus infection
10/17/2002	CA2443303A1 Method for preparing and selecting antibodies
10/17/2002	CA2443293A1 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
10/17/2002	CA2443277A1 Interferon gamma polypeptide variants
10/17/2002	CA2443275A1 Improved gene expression
10/17/2002	CA2443060A1 Methods and gel compositions for encapsulating living cells and organic molecules
10/17/2002	CA2443032A1 Scaffold matrix and tissue maintaining systems
10/17/2002	CA2442915A1 Compositions and method for enhancing proteoglycan production
10/17/2002	CA2442911A1 Bioluminescent plants and methods of making same
10/17/2002	CA2442868A1 Chitosan and hydroxy carboxylic acid based porous and non-porous matrices
10/17/2002	CA2442839A1 Production and use of novel peptide-based agents for use with bi-specific antibodies
10/17/2002	CA2442817A1 Implantation serine proteinases
10/17/2002	CA2442739A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/17/2002	CA2442386A1 Epitope sequences
10/17/2002	CA2442315A1 Glycosaminoglycan/collagen complexes and use thereof
10/17/2002	CA2442092A1 Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication
10/17/2002	CA2435528A1 Novel polypeptides and nucleic acids encoded thereby
10/17/2002	CA2429376A1 Mitogenic oxygenase regulators
10/16/2002	EP1249496A2 Methods for producing and transforming cassava protoplasts
10/16/2002	EP1249491A2 Human very long chain acyl-CoA synthase (VLCAS)-like protein and nucleic acids encoding it
10/16/2002	EP1249490A2 In vitro activation of cytotoxic T cells
10/16/2002	EP1249160A1 Model animal with favorite onset of rheumatoid arthritis
10/16/2002	EP1248858A1 Antisense modulation of caspase 8 expression
10/16/2002	EP1248849A1 Obg3 globular head and uses thereof for decreasing body mass
10/16/2002	EP1248848A1 Methods and materials relating to stem cell growth factor-like poypeptides and polynucleotides
10/16/2002	EP1248847A1 Irak-4: compositions and methods of use
10/16/2002	EP1248843A2 Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses
10/16/2002	EP1248841A2 Genes differentially expressed in breast cancer
10/16/2002	EP1248836A2 Hybrid cells obtainable from antigen presenting cells

1 ... 1288 1289 1290 1291 1292 1293 1294 1295 1296 1297 1298 1299 1300 1301 1302 1303 1304 1305 1306 1307 1308 ... 1827